Aprepitant Pellets
Aprepitant Pellets 40.0% – Ready to Fill Into Capsules (Dose: 40 mg, 80 mg, or 125 mg)
Aprepitant is used for the prevention of acute and delayed chemotherapy-induced nausea and vomiting (CINV), and for prevention of postoperative nausea and vomiting (PONV). It is a selective high-affinity antagonist of human substance P/neurokinin 1 (NK1) receptors.
- Development services available for different formulations, dosages, or strengths.
- Complete technical package available for registrations in all regulated/semi-regulated markets.
Additional Information
| Percentage | 15%, 40% |
|---|---|
| Release Type | Immediate Release |
| Target Formulations | Capsules, Injectables |
| Documentation Available: | DMF in CTD Format |
| Forms of PFI | Pellets/Micro pellets (for capsules) |
| Quality Standard | USP43 |
